Breaking News, Collaborations & Alliances

3P Bio, In3Bio Enter Cancer Pact

New anti-tumor treatment is one step closer to the clinic on heels of new collaboration.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

3P Biopharmaceuticals, a contract development and manufacturing organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has been chosen by In3Bio, a UK based biotech, to collaborate in the development of a novel anti-tumor treatment. 3P Biopharmaceuticals and In3Bio began their partnership in early 2019 with 3P Biopharmaceuticals being selected to be responsible for technology transfer, process development, analytical methods development, scale-up and cGMP pr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters